Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

European marketing approval for Kivexa

Dec. 27, 2004

BMS and Gilead to develop fixed combination HIV medication

Dec. 22, 2004

NIAID approval for advanced preclinical testing of Mymetics' HIV vaccine

Dec. 22, 2004

New Invirase 500 mg receives FDA approval

Dec. 21, 2004

Milestone in Merck's PER.C6-related HIV program

Dec. 20, 2004

Phase IIa study of PA-457 in HIV patients

Dec. 14, 2004

Launch of Fuzeon Accelerated Simultaneous Access Program

Dec. 7, 2004

Good safety profile reported for C31G vaginal gel in healthy volunteers

Dec. 1, 2004

Positive preliminary results from phase I/II study of PA-457

Nov. 25, 2004

Enrollment completed in phase II lipodystrophy study of EG-005

Nov. 25, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...